January 2, 2018

NEW YORK CITY EMPLOYEES' RETIREMENT SYSTEM et al v. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. January 2, 2018

    Funds Say Valeant Price-Gouging Probe Cost Them $80B

    Valeant Pharmaceuticals International Inc.’s alleged price-gouging scheme cost shareholders more than $80 billion once the scheme came to light, investors said in a suit filed in New Jersey district court Tuesday.


Parties

To view the parties, register now.